HemoClear selected for EIT Health Bridgehead Europe programme

The renowned European Institute for Innovation and Technology (EIT) has selected HemoClear to participate in the Bridgehead Europe programme.

Best-in-class health care innovators

In this prestigious program, the best-in-class health care innovators are connected for collaboration with the brightest minds in healthcare. During the 12 month programme HemoClear will also be granted financial support to support internationalization activities.

β€˜β€™To participate in the EIT Bridgehead program is, besides an important recognition of our blood transfusion solutions, a tremendous accelerator of our international commercialization activities,’’ says Vincent Franssen, chief executive officer at HemoClear.

We are looking forward to the upcoming Bridgehead Europe Matchmaking Event on 30 June-July 1 2020 were we will select a program partner from the Bridgehead network.

Leave a Reply

Your email address will not be published. Required fields are marked *